Determination of β-Amyloid Peptide Signatures in Cerebrospinal Fluid Using Immunoprecipitation-Mass Spectrometry

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · see citing works

The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease

Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · see citing works

Metabolic Regulation of Brain Aβ by Neprilysin

Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N., Gerard, C., Hama, E., Lee, H., & Saido, T. (2001) · Science · doi:10.1126/science.1059946 · Cited by 894 · see citing works

Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death

Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 708 · see citing works

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease

Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.673 · Cited by 660 · see citing works

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582 · see citing works

Contact-Dependent Inhibition of Cortical Neurite Growth Mediated by Notch Signaling

Šestan, N., Artavanis‐Tsakonas, S., & RAKIC, P. T. (1999) · Science · doi:10.1126/science.286.5440.741 · Cited by 571 · see citing works

ADAMs family members as amyloid precursor protein α‐secretases

Allinson, T. M. J., Parkin, E. T., Turner, A. J., & Hooper, N. M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10737 · Cited by 441 · see citing works

Simultaneous Measurement of β-Amyloid(1–42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Olsson, A., Vanderstichele, H., Andreasen, N., Meyer, G. D., Wallin, A., Holmberg, B., Rosengren, L., Vanmechelen, E., & Blennow, K. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039347 · Cited by 424 · see citing works

Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid

Vigo‐Pelfrey, C., Lee, D., Keim, P., Lieberburg, I., & Schenk, D. B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09841.x · Cited by 385 · see citing works

Mapping Aβ Amyloid Fibril Secondary Structure Using Scanning Proline Mutagenesis

Williams, A. D., Portelius, E., Kheterpal, I., Guo, J., Cook, K. D., Xu, Y., & Wetzel, R. B. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.11.008 · Cited by 378 · see citing works

Degradation of the Alzheimer's Amyloid β Peptide by Endothelin-converting Enzyme*

Eckman, E., Reed, D. K., & Eckman, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007579200 · Cited by 345 · see citing works

The Plasmin System Is Induced by and Degrades Amyloid-β Aggregates

Tucker, H. M., Kihiko‐Ehmann, M., Caldwell, J. N., Wright, S., Kawarabayashi, T., PRICE, D. A., Walker, D., Scheff, S. W., McGillis, J. P., Rydel, R. E., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-03937.2000 · Cited by 306 · see citing works

The Profile of Soluble Amyloid β Protein in Cultured Cell Media

Wang, R., Sweeney, D. A., Gandy, S., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31894 · Cited by 293 · see citing works

Metabolism of amyloid-β peptide and Alzheimer's disease

Iwata, N., Higuchi, M., & Saido, T. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.010 · Cited by 216 · see citing works

Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism

Howell, S. W., Nalbantoglu, J. N., & Crine, P. (1995) · Peptides · doi:10.1016/0196-9781(95)00021-b · Cited by 204 · see citing works

Structural Features of the Aβ Amyloid Fibril Elucidated by Limited Proteolysis

Kheterpal, I., Williams, A. D., Murphy, C. L., Bledsoe, B., & Wetzel, R. B. (2001) · Biochemistry · doi:10.1021/bi010805z · Cited by 199 · see citing works

γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying Length

Murphy, M. P., Hickman, L., Eckman, C. B., Uljon, S., Wang, R., & Golde, T. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11914 · Cited by 156 · see citing works

Structural properties of Aβ protofibrils stabilized by a small molecule

Williams, A. D., Sega, M., Chen, M., Kheterpal, I., Geva, M., Berthelier, V., Kaleta, D. T., Cook, K. D., & Wetzel, R. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408582102 · Cited by 132 · see citing works

Insulysin Hydrolyzes Amyloid β Peptides to Products That Are Neither Neurotoxic Nor Deposit on Amyloid Plaques

Mukherjee, A., Song, E.-S., Kihiko‐Ehmann, M., Goodman, J. P., Pyrek, J. S., Estus, S., & Hersh, L. B. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08745.2000 · Cited by 127 · see citing works

Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention

Eckman, E. A., & Eckman, C. B. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331101 · Cited by 116 · see citing works

Plasmin Cleavage of the Amyloid β-Protein: Alteration of Secondary Structure and Stimulation of Tissue Plasminogen Activator Activity

Nostrand, W. E. V., & Porter, M. D. (1999) · Biochemistry · doi:10.1021/bi990610f · Cited by 113 · see citing works

Kinetics of Amyloid β-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based Assays

Leissring, M. A., Lu, A., Condron, M. M., Teplow, D. B., Stein, R. L., Farris, W., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305627200 · Cited by 113 · see citing works

Plasma Levels of β-Amyloid(1-40), β-Amyloid(1-42), and Total β-Amyloid Remain Unaffected in Adult Patients With Hypercholesterolemia After Treatment With Statins

Höglund, K., Wiklund, O., Vanderstichele, H., Eikenberg, O., Vanmechelen, E., & Blennow, K. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.333 · Cited by 102 · see citing works

The amyloid‐ β (A β ) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated A β peptide

Lewczuk, P., Esselmann, H., Meyer, M., Wollscheid, V., Neumann, M., Otto, M., Maler, J. M., Rüther, E., Kornhuber, J., & Wiltfang, J. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1048 · Cited by 100 · see citing works

Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization

Chesneau, V., Vekrellis, K., Rosner, M. R., & Selkoe, D. J. (2000) · Biochemical Journal · doi:10.1042/bj3510509 · Cited by 91 · see citing works

Generation of C‐terminally truncated amyloid‐β peptides is dependent on γ‐secretase activity

Beher, D., Wrigley, J. D. J., Owens, A. P., & Shearman, M. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00985.x · Cited by 83 · see citing works

Identification of a β-Secretase Activity, Which Truncates Amyloid β-Peptide after Its Presenilin-dependent Generation

Fluhrer, R., Multhaup, G., Schlicksupp, A., Okochi, M., Takeda, M., Lammich, S., Willem, M., Westmeyer, G. G., Bode, W., Walter, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211485200 · Cited by 81 · see citing works

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

Maddalena, A. S., Papassotiropoulos, A., Gonzalez-Agosti, C., Signorell, A., Hegi, T., Pasch, T., Nitsch, R. M., & Höck, C. (2004) · Neurodegenerative Diseases · doi:10.1159/000080991 · Cited by 74 · see citing works

The functional γ-secretase inhibitor prevents production of amyloid β 1–34 in human and murine cell lines

Vandermeeren, M., Geraerts, M., Pype, S., Dillen, L., Hove, C. V., & Mercken, M. H. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02369-2 · Cited by 39 · see citing works

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · see citing works

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863 · see citing works

Biomarkers for Alzheimer's disease: current status and prospects for the future

Blennow, K., & Zetterberg, H. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12816 · Cited by 1,000 · see citing works

Current state of Alzheimer’s fluid biomarkers

Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518 · see citing works

Amyloid biomarkers in Alzheimer's disease

Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.002 · Cited by 470 · see citing works

Fluid Biomarkers in Alzheimer Disease

Blennow, K., Zetterberg, H., & Fagan, A. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006221 · Cited by 208 · see citing works

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain

Wildburger, N. C., Esparza, T. J., LeDuc, R. D., Fellers, R. T., Thomas, P. M., Cairns, N. J., Kelleher, N. L., Bateman, R. J., & Brody, D. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10422-x · Cited by 164 · see citing works

Drug development for Alzheimer’s disease: Review

Lao, K., Ji, N., Zhang, X., Qiao, W., Tang, Z., & Gou, X. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474361 · Cited by 86 · see citing works

Putting humpty dumpty back together again: what does protein quantification mean in bottom-up proteomics?

Plubell, D. L., Käll, L., Webb-Robertson, B.-J., Bramer, L. M., Ives, A., Kelleher, N. L., Smith, L. M., Montine, T. J., Wu, C. C., & MacCoss, M. J. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00894 · Cited by 85 · see citing works

γ-Secretase and its modulators: Twenty years and beyond

Xia, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.011 · Cited by 54 · see citing works

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

Augutis, K., Axelsson, M., Portelius, E., Brinkmalm, G., Andreasson, U., Gustavsson, M. K., Malmeström, C., Lycke, J., Blennow, K., Zetterberg, H., et al. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458512460603 · Cited by 47 · see citing works

Identification and properties of a neuropeptide-degrading endopeptidase (neprilysin) ofAscaris suummuscle

Sajid, M., & Isaac, R. E. (1995) · Parasitology · doi:10.1017/s0031182000077088 · Cited by 23 · see citing works

A highly sensitive peptide substrate for detecting two Aβ-degrading enzymes: Neprilysin and insulin-degrading enzyme

Chen, P., Liao, T., Hu, C., Wu, S.-T., Wang, S. S. ‐., & Chen, R. P. ‐. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.04.024 · Cited by 21 · see citing works

Endopeptidase-24.11 (Neprilysin) and Relatives

Turner, A. J., Murphy, L. J., Medeiros, M. S., & Barnes, K. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0335-0_17 · Cited by 16 · see citing works

Involvement of endopeptidase-24.11 in degradation of substance P by glioma cells

Endo, S., Yokosawa, H., & Ishii, S. (1989) · Neuropeptides · doi:10.1016/0143-4179(89)90042-5 · Cited by 13 · see citing works

Regulatory peptide metabolism at cell surfaces: the key role of endopeptidase-24.11.

Kenny, A. J. (1986) · PubMed · Cited by 24 · see citing works